|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2004-3-23
|
|
pubmed:abstractText |
This study reanalysed the results of the Cs-137 low-dose-rate brachytherapy trials for stage I and II cervix carcinoma at the Christie Hospital, Manchester, UK, in order to quantify the clinical outcome as a function of dose, and to extract radiobiological parameter values by modelling the data for local control and morbidity.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0167-8140
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
70
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
63-74
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15036854-Brachytherapy,
pubmed-meshheading:15036854-Carcinoma, Squamous Cell,
pubmed-meshheading:15036854-Cesium Radioisotopes,
pubmed-meshheading:15036854-Dose-Response Relationship, Radiation,
pubmed-meshheading:15036854-Female,
pubmed-meshheading:15036854-Humans,
pubmed-meshheading:15036854-Middle Aged,
pubmed-meshheading:15036854-Neoplasm Recurrence, Local,
pubmed-meshheading:15036854-Neoplasm Staging,
pubmed-meshheading:15036854-Radiotherapy Dosage,
pubmed-meshheading:15036854-Treatment Outcome,
pubmed-meshheading:15036854-Uterine Cervical Neoplasms
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Compensation for changes in dose-rate in radical low-dose-rate brachytherapy: a radiobiological analysis of a randomised clinical trial.
|
|
pubmed:affiliation |
Biostatistics Group, School of Epidemiology and Health Sciences, University of Manchester, Manchester M13 9PT, UK.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
